U.S. Consumer Durables Stock News

Why Live Nation’s 2025 milestones have investors’ attention Live Nation Entertainment (LYV) is back in focus after reporting record adjusted operating income in its Concerts segment for 2025, hosting 159 million fans and outlining new venue openings across Latin America, Europe, and the U.S. See our latest analysis for Live Nation Entertainment. Live Nation’s latest results arrive after a 7.11% 90 day share price return and a 13.35% 1 year total shareholder return, which build on a very large...

BWX Technologies (BWXT) has been drawn into the University of Missouri’s NextGen MURR research reactor project as a subcontractor to Burns & McDonnell, linking the stock to expanded nuclear medicine and research activity. See our latest analysis for BWX Technologies. The NextGen MURR contract news lands while BWX Technologies’ share price has a 90 day share price return of 23.13% and a 1 year total shareholder return of 110.21%. This suggests momentum has been building despite some recent...

Index changes put Molina Healthcare in focus Molina Healthcare (MOH) has been removed from the FTSE All-World Index and added to the Russell Small Cap Comp Value and Growth Indices, a reshuffle that can influence trading flows and institutional ownership. These moves often prompt index-tracking funds to adjust positions, which can affect liquidity and short term price behavior. For current and prospective shareholders, they raise practical questions about how MOH is being classified in the...

Joby Aviation recently completed the first test flight of its FAA Type Inspection Authorization aircraft N547JX in Marina, California, a major step in the rigorous certification process for its electric air taxi service. This milestone moves Joby into the most demanding phase of FAA testing, where regulators will evaluate whether its conforming eVTOL fleet can ultimately be used for commercial operations in the U.S. and abroad. Now we’ll examine how entering FAA Type Inspection...

Why Dell Technologies has caught investors' attention Dell Technologies (DELL) has attracted fresh interest after its shares closed at $169.38, with recent returns showing mixed short term moves and stronger gains over the past month and past 3 months. For investors, the current share price sits alongside a value score of 5 and an intrinsic discount indicator of 34.19%. Together, these figures raise questions about how the market is currently weighing Dell’s fundamentals. See our latest...

Iran's Islamic Revolutionary Guard Corps recently labeled Cisco Systems (NasdaqGS:CSCO) and other U.S. tech firms as "legitimate targets" in the Middle East. The IRGC cited perceived involvement of these companies in regional conflicts and referenced prior attacks on Western tech infrastructure. Employees of Cisco and peers were directly warned, elevating concerns about physical security, operational continuity, and critical network assets in the region. Cisco Systems, traded as...

Enterprise Products Partners (EPD) has been back in focus after a series of upbeat analyst updates and a sharp 18.5% drop in short interest during March, signaling shifting sentiment around this large midstream partnership. See our latest analysis for Enterprise Products Partners. At a share price of US$37.43, Enterprise Products Partners has seen a 90 day share price return of 16.75% and a 1 year total shareholder return of 17.74%. The recent 7 day pullback and reduced short interest suggest...

W. P. Carey (WPC) is drawing fresh attention after completing about $580 million in first quarter investments, capped by a $210 million Canadian auto dealership sale leaseback and active capital markets activity that supported these deals. See our latest analysis for W. P. Carey. At a share price of $69.39, W. P. Carey has a 1 day share price return of 2.10% and a 90 day share price return of 7.82%. Its 1 year total shareholder return of 17.06% suggests momentum has been building over a...

Event context and recent share performance Vertex (VERX) has been drawing investor attention after a period of weaker share performance, with the stock down about 16% over the past month and about 39% over the past 3 months. See our latest analysis for Vertex. Against a backdrop of weak longer term results, including a 1 year total shareholder return of about 67% in decline, the recent 7 day share price return of 3.69% at a share price of $12.09 hints that downside momentum may be easing...

Wondering whether FactSet Research Systems at around US$224.86 is starting to look like value, or if the recent excitement has already been priced in. The stock has moved 16.0% over the last 7 days and 2.2% over the past month, yet year to date it is down 21.1% and the 1 year return sits at a 49.5% decline. These swings have kept attention on what the current share price actually reflects about the business. This is especially the case after a year where longer term returns, such as the 3...

Recent price performance snapshot CME Group (CME) has drawn investor attention after recent trading, with the share price around $296.94 and mixed returns across different periods, including a negative move over the past month and a positive trend over the past 3 months. See our latest analysis for CME Group. For context, CME Group’s 1 month share price return of a 9.04% decline contrasts with a 10.11% share price gain year to date. The 5 year total shareholder return of 79.09% points to...

HCA Healthcare recently announced that the HCA Healthcare Foundation will provide a US$2.00 million grant to Second Harvest Food Bank of Middle Tennessee to support its new Grow for Good campus in Nashville, alongside highlighting a mixed quarterly report with revenue slightly below expectations but earnings per share ahead of forecasts. The combination of continued investment in network expansion and workforce development, together with community-focused initiatives like Grow for Good,...

In March 2026, Synopsys, Inc. announced a multi-billion-dollar private placement of common shares with participation from new investor Elliott Investment Management L.P., and earlier that month Arm revealed a collaboration with Synopsys on the Arm AGI CPU using Synopsys’ full-stack design tools and IP. This combination of fresh capital and deeper alignment with Arm’s Neoverse ecosystem highlights Synopsys’ role in enabling next-generation custom silicon and complex compute systems. Next,...

In March 2026, Synchrony Financial announced a partnership with Figo Pet Insurance that lets pet owners use CareCredit to pay upfront vet bills and receive approved insurance reimbursements directly as credits to their CareCredit accounts. This integration expands CareCredit’s pet insurance reimbursement ecosystem to more than 1.20 billion insured policyholders across Figo, Pets Best, and Pumpkin, simplifying veterinary payments for customers and clinics. Next, we’ll examine how this...

AirSculpt Technologies (AIRS) has wrapped up FY 2025 with Q4 revenue of US$33.4 million and net income of US$1.3 million, translating to basic EPS of US$0.02. Over the trailing twelve months, the company reported revenue of US$151.8 million and a net loss of US$11.7 million, or a basic EPS loss of US$0.19. During FY 2025, quarterly revenue ranged from US$33.4 million to US$44.0 million, while basic EPS moved between a loss of US$0.15 and a small profit of US$0.02. This puts the latest quarter...

In late March 2026, IonQ’s shares weakened as heightened geopolitical tensions in the Middle East, particularly the conflict with Iran, weighed on broader equity markets and dampened risk appetite. At the same time, IonQ’s memorandum of understanding with South Korea’s KISTI to integrate its quantum systems with local high-performance computing highlights the company’s growing role in global quantum infrastructure and workforce development. Against this backdrop, we’ll explore how...

Tarsus Pharmaceuticals (TARS) has drawn fresh attention after dosing the first participant in its Phase 2 Calliope trial of TP-05, an oral candidate aimed at preventing Lyme disease by killing infected ticks. See our latest analysis for Tarsus Pharmaceuticals. The recent TP-05 progress and TP-03 milestone in China come as the share price sits at US$70.22, with a 7 day share price return of 4.9% but a 90 day share price return showing a 14.2% decline. The 1 year total shareholder return of...

If you are wondering whether Legend Biotech's share price reflects its underlying value, this article breaks down what the current market price may be implying about the company. The stock closed at US$19.05, with returns of 8.2% over the last week and 3.3% over the last month. The 1 year return stands at a 42.7% decline and the 3 year return at a 60.5% decline. Recent coverage around Legend Biotech has focused on its position in the biotech space and how investors are reassessing risk and...

Ameresco (NYSE:AMRC) has introduced a dual Co President structure alongside the appointment of a new Chief Operating Officer. The leadership changes mark a major organizational restructure aimed at supporting growth and project execution across the business. Ameresco focuses on energy efficiency, renewable energy projects, and related services, an area that depends heavily on disciplined project management and long term contracts. As the company works across government, commercial, and...

If you are wondering whether Millrose Properties at US$28.51 still offers value after its recent run, this article will help you frame that question clearly. The stock has seen a 3.1% decline over the last 7 days and an 8.0% decline over the last 30 days, while still showing a 17.4% return over the last year and a 4.4% decline year to date. Recent news flow around Millrose Properties has focused on its position within the real estate sector and how sentiment toward property related names has...

If you are wondering whether ONEOK is priced fairly or if the current share price leaves some value on the table, this breakdown will help you frame that question in a structured way. With the stock at US$87.36, recent returns have been mixed, including a 5.2% decline over the last 7 days, a 1.4% return over 30 days, 17.5% year to date, and an 8.1% decline over the past year, set against a 54.9% and 126.6% return over 3 and 5 years respectively. Recent coverage has largely focused on ONEOK's...

Why Bank of New York Mellon Corporation (BK) Is On Investors’ Radar Bank of New York Mellon Corporation (BK) has attracted attention after a solid run, with total return figures over the past year and past 3 years prompting fresh interest in how the stock is currently priced. See our latest analysis for Bank of New York Mellon. With the share price at $120.97 and a 1-day share price return of 1.97%, recent gains add to a steady upward trend. The 1-year total shareholder return of 46.66% and...

Recent performance context for Paychex stock Paychex (PAYX) has seen its share price under pressure recently, with negative returns over the past week, month and past 3 months, and a 39.26% decline over the past year. See our latest analysis for Paychex. At a share price of US$90.91, the stock’s recent slide is consistent with its 18.96% 3 month share price decline and 39.26% 1 year total shareholder return decline. This suggests momentum has been fading as investors reassess growth prospects...

In late March 2026, Royal Gold, Inc. issued 2026 guidance calling for higher gold, silver, and copper sales volumes than 2025, outlined expectations for minor contributions from other metals based on assumed reference prices, and indicated that sales would be slightly weighted toward the second half of the year. The company also repaid US$125 million on its revolving credit facility, published a detailed 2025/2026 Asset Handbook, and introduced a new five-year outlook that together give...